Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-24-016101

VP, Clinical Trial Operations bought 2,500 shares

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Yu Yong VP, Clinical Trial Operations 2024-05-29 Purchase +2,500 2,500 D
Derivatives
Yu Yong VP, Clinical Trial Operations 2024-05-29 Purchase · Common Stock Warrant (Right to Buy) +2,500 2,500 D
Open-market purchases · 2,500 sh
Loading xslF345X05/form4-06072024_090610.xml…